Cargando…

Case Report: Infection With SARS-CoV-2 in the Presence of High Levels of Vaccine-Induced Neutralizing Antibody Responses

We present a case of SARS-CoV-2 B.1. 525 infection in a healthcare worker despite the presence of highly neutralizing, multivariant-specific antibodies 7 weeks after full vaccination with the mRNA vaccine BNT162b2. We show that the virus replicated to high levels in the upper respiratory tract over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulte, Bianca, Marx, Benjamin, Korencak, Marek, Emmert, Dorian, Aldabbagh, Souhaib, Eis-Hübinger, Anna Maria, Streeck, Hendrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342944/ https://www.ncbi.nlm.nih.gov/pubmed/34368197 http://dx.doi.org/10.3389/fmed.2021.704719

Ejemplares similares

Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections
por: Richter, Enrico, et al.
Publicado: (2021)

Ad hoc laboratory-based surveillance of SARS-CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples
por: Eis-Hübinger, Anna M., et al.
Publicado: (2020)

Reconstruction of the origin of the first major SARS-CoV-2 outbreak in Germany
por: Korencak, Marek, et al.
Publicado: (2022)

Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity
por: Döhla, M., et al.
Publicado: (2020)

Characteristic Temporary Loss of Taste and Olfactory Senses in SARS-CoV-2-positive-Individuals with Mild Symptoms
por: Schmithausen, Ricarda M., et al.
Publicado: (2020)

SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study)
por: van Bremen, Kathrin, et al.
Publicado: (2021)

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?
por: Menting, T., et al.
Publicado: (2021)

SARS-CoV-2 in Environmental Samples of Quarantined Households
por: Döhla, Manuel, et al.
Publicado: (2022)

Basic research on herpes simplex viruses: are mutants still needed?
por: Matz, Bertfried, et al.
Publicado: (2023)

Hepatitis B virus subgenotype F3 reactivation with vaccine escape mutations: A case report and review of the literature
por: Schlabe, Stefan, et al.
Publicado: (2018)

COVID-19 reinfection in the presence of neutralizing antibodies
por: Zhang, Ju, et al.
Publicado: (2021)

Correlation between a quantitative anti‐SARS‐CoV‐2 IgG ELISA and neutralization activity
por: Dolscheid‐Pommerich, Ramona, et al.
Publicado: (2021)

Suppression of CMV Infection with Letermovir in a Kidney Transplant Patient
por: Koepf, Uta S, et al.
Publicado: (2020)

Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
por: Streeck, Hendrik, et al.
Publicado: (2020)

Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection
por: Mu, Song, et al.
Publicado: (2022)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

W102 Correlation between the atellica SARS-COV-2 IGG assay results and the presence of SARS-COV-2 neutralizing antibodies
por: Bedini, J., et al.
Publicado: (2022)

SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies
por: Brehm, Thomas Theo, et al.
Publicado: (2021)

Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
por: Pušnik, Jernej, et al.
Publicado: (2022)

Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies
por: Girl, Philipp, et al.
Publicado: (2022)

1336. Presence of Antibodies to non-SARS-CoV-2 Associates With Generation of Neutralizing Antibodies to SARS-CoV-2 Following mRNA Vaccination
por: Al Hammoud, Roukaya, et al.
Publicado: (2023)

Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections
por: Lai, Rongtao, et al.
Publicado: (2021)

Binding and neutralizing antibody responses to SARS-CoV-2 in very young children exceed those in adults
por: Karron, Ruth A., et al.
Publicado: (2022)

Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help
por: Pušnik, Jernej, et al.
Publicado: (2021)

Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
por: Richter, Enrico, et al.
Publicado: (2023)

Fast Detection of SARS-CoV-2 RNA Directly from Respiratory Samples Using a Loop-Mediated Isothermal Amplification (LAMP) Test
por: Anastasiou, Olympia E., et al.
Publicado: (2021)

T cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity
por: Elyanow, Rebecca, et al.
Publicado: (2022)

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
por: Hvidt, Astrid K., et al.
Publicado: (2022)

Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes
por: Bojkova, Denisa, et al.
Publicado: (2020)

The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms
por: Buck, Amanda M., et al.
Publicado: (2023)

Neutralizing antibody titres in SARS-CoV-2 infections
por: Lau, Eric H. Y., et al.
Publicado: (2021)

Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigens
por: Alt, Mira, et al.
Publicado: (2018)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

The infectivity of progeny adenovirus in the presence of neutralizing antibody
por: Hirai, Takamasa, et al.
Publicado: (2021)

Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis—A case report and literature review
por: Yalcin Mutlu, Melek, et al.
Publicado: (2022)

Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review
por: Gutlapalli, Sai Dheeraj, et al.
Publicado: (2023)

Asprosin-neutralizing antibodies as a treatment for metabolic syndrome
por: Mishra, Ila, et al.
Publicado: (2021)

The presence of SARS-CoV2 antibodies in MS patients
por: Wallach, Asya I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_141f5jp8575qsednd55eko00ul